Open access · CC-BY
via OpenAlex
DNAJB6 suppresses alpha-synuclein induced pathology in an animal model of Parkinson's disease
Sertan Arkan, Mårten Ljungberg, Deniz Kirik, Christian Hansen
Neurobiology of Disease · 2021 · ▲ 40 citations
Abstract
BACKGROUND: α-synuclein (α-syn) aggregation can lead to degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc) as invariably observed in patients with Parkinson's Disease (PD). The co-chaperone DNAJB6 has previously been found to be expressed at higher levels in PD patients than in control subjects and was also found in Lewy bodies. Our previous experiments showed that knock out of DNAJB6 induced α-syn aggregation in cellular level. However, effects of overexpression of DNAJB6 against α-syn aggregation remains to be investigated. METHODS: We used a α-syn CFP/YFP HEK293 FRET cell line to investigate the effects of overexpression of DNAJB6 in cellular level. α-syn aggregation was induced by transfection α-syn preformed fibrils (PPF), then was measured FRET analysis. We proceeded to investigate if DNAJB6b can impair α-syn aggregation and toxicity in an animal model and used adeno associated vira (AAV6) designed to overexpress of human wt α-syn, GFP-DNAJB6 or GFP in rats. These vectors were injected into the SNpc of the rats, unilaterally. Rats injected with vira to express α-syn along with GFP in the SNpc where compared to rats expressing α-syn and GFP-DNAJB6. We evaluated motor functions, dopaminergic cell death, and axonal degeneration in striatum. RESULTS: We show that DNAJB6 prevent α-syn aggregation induced by α-syn PFF's, in a cell culture model. In addition, we observed α-syn overexpression caused dopaminergic cell death and that this was strongly reduced by co-expression of DNAJB6b. The lesion caused by α-syn overexpression resulted in behavior deficits, which increased over time as seen in stepping test, which was rescued by co-expression of DNAJB6b. CONCLUSION: We here demonstrate for the first time that DNAJB6 is a strong suppressor of α-syn aggregation in cells and in animals and that this results in a suppression of dopaminergic cell death and PD related motor deficits in an animal model of PD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.nbd.2021.105477
- Canonical
- link ↗
- Fetched
- 2026-10-21 MST
Cite this
APA
Arkan, S., Ljungberg, M., Kirik, D., & Hansen, C. (2021). DNAJB6 suppresses alpha-synuclein induced pathology in an animal model of Parkinson's disease. <em>Neurobiology of Disease</em>. https://doi.org/10.1016/j.nbd.2021.105477
Vancouver
Arkan S, Ljungberg M, Kirik D, Hansen C. DNAJB6 suppresses alpha-synuclein induced pathology in an animal model of Parkinson's disease. Neurobiology of Disease. 2021. doi:10.1016/j.nbd.2021.105477.
BibTeX
@article{sertan2021DNAJBs,
title = {DNAJB6 suppresses alpha-synuclein induced pathology in an animal model of Parkinson's disease},
author = {Sertan Arkan and Mårten Ljungberg and Deniz Kirik and Christian Hansen},
journal = {Neurobiology of Disease},
year = {2021},
doi = {10.1016/j.nbd.2021.105477},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2010
Open access · CC-BY
Microglia Acquire Distinct Activation Profiles Depending on the Degree of α-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease
Neurobiology of Disease 2024
Open access · CC-BY
Elucidating the mechanisms of α-Synuclein-lipid interactions using site-directed mutagenesis
Journal of Neuroscience 2014
Open access · OA
Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models
PLoS ONE 2012
Open access · CC-BY
The Role of Alpha-Synuclein Oligomerization and Aggregation in Cellular and Animal Models of Parkinson’s Disease
Journal of the Neurological Sciences 2023
Open access · CC-BY
Alpha-synuclein in skin as a high-quality biomarker for Parkinson's disease
Scientific Reports 2024
Open access · CC-BY